generic

related words
marketed
therapy
exclusivity
branded
corlux
cancer
diminished
defective
cell
version
asserted
reimburse
orphan
misuse
tissue
stabilizing
image
therapeutic
laser
malpractice
related documents
69499--5/16/2006--MYLAN_LABORATORIES_INC
729922--2/24/2010--OSI_PHARMACEUTICALS_INC
1235010--3/12/2010--MOMENTA_PHARMACEUTICALS_INC
1113481--3/16/2010--MEDICINES_CO_/DE
885590--2/26/2010--BIOVAIL_CORP_INTERNATIONAL
887708--6/15/2009--CARACO_PHARMACEUTICAL_LABORATORIES_LTD
310158--2/27/2009--SCHERING_PLOUGH_CORP
729922--2/27/2009--OSI_PHARMACEUTICALS_INC
1235010--3/13/2009--MOMENTA_PHARMACEUTICALS_INC
1145404--3/26/2009--CORNERSTONE_THERAPEUTICS_INC
887708--6/10/2008--CARACO_PHARMACEUTICAL_LABORATORIES_LTD
310158--2/29/2008--SCHERING_PLOUGH_CORP
729922--2/28/2008--OSI_PHARMACEUTICALS_INC
927829--3/6/2008--NITROMED_INC
737207--3/17/2008--NASTECH_PHARMACEUTICAL_CO_INC
1235010--3/10/2008--MOMENTA_PHARMACEUTICALS_INC
887708--5/14/2007--CARACO_PHARMACEUTICAL_LABORATORIES_LTD
310158--2/28/2007--SCHERING_PLOUGH_CORP
737207--3/7/2007--NASTECH_PHARMACEUTICAL_CO_INC
887708--6/14/2006--CARACO_PHARMACEUTICAL_LABORATORIES_LTD
related topics
{product, liability, claim}
{property, intellectual, protect}
{product, candidate, development}
{product, market, service}
{condition, economic, financial}
{interest, director, officer}
{tax, income, asset}
{gas, price, oil}
{regulation, government, change}
{customer, product, revenue}
{loan, real, estate}
{provision, law, control}
{competitive, industry, competition}
{capital, credit, financial}
{investment, property, distribution}
{control, financial, internal}
{cost, contract, operation}
{cost, operation, labor}
{regulation, change, law}
{stock, price, share}